Your browser doesn't support javascript.
loading
Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis.
Wilk, Christian Matthias; Heinzler, Niklas; Boquoi, Amelie; Cadeddu, Ron-Patrick; Strapatsas, Tobias; Dienst, Ariane; Majidi, Fatemeh; Deenen, René; Bruns, Ingmar; Schroeder, Thomas; Köhrer, Karl; Haas, Rainer; Kobbe, Guido; Fenk, Roland.
Afiliación
  • Wilk CM; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Heinzler N; Hematology, University and University Hospital Zurich, Zurich, Switzerland.
  • Boquoi A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Cadeddu RP; Department of Diagnostic and Interventional Radiology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Strapatsas T; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Dienst A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Majidi F; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Deenen R; Division of Emergency Care, Helios Klinikum Wuppertal, Wuppertal, Germany.
  • Bruns I; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Köhrer K; Biologisch-Medizinisches Forschungszentrum (BMFZ), Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Haas R; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York.
  • Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf and Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
  • Fenk R; Biologisch-Medizinisches Forschungszentrum (BMFZ), Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Int J Cancer ; 139(10): 2343-52, 2016 Nov 15.
Article en En | MEDLINE | ID: mdl-27389073
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talidomida / Mielopoyesis / Eritropoyesis / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talidomida / Mielopoyesis / Eritropoyesis / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Alemania